Terminated NCT06972745
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
In México Schizophrenia Behavioral Over 18 Years
Countries Mexico
Sponsor Hospital Psiquiátrico Fray Bernardino Álvarez
Condition Schizophrenia Completed NCT04977856
This study is looking at whether Behavioral activation (BA) can help people with depression. Participants take part in Behavioral activation (BA) and complete follow-up assessments.
In Stockholm Depression Behavioral From 13 Years to 17 Years
Countries Sweden
Sponsor Region Stockholm
Condition Depression Terminated EUCTR 2007-001520-12
This study was terminated in Portugal. It focuses on Schizophrenia.
In Portugal Schizophrenia Other
Countries Portugal
Sponsor Unidade de Investigação em Saúde Mental e Psiquiatria do Centro Hospitalar Conde de Ferreira
Condition Schizophrenia Completed NCT00482313
This summary needs review. Please check the official study record and contact the research team for details.
In Huddinge ADHD Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries Sweden
Sponsor Psychiatry Karolinska
Condition ADHD Ongoing EUCTR 2020-002905-24
This study is ongoing in the Netherlands. It focuses on Suicide prevention.
In Netherlands Suicidality Other
Countries Netherlands
Sponsor University Medical Center Groningen
Condition Suicidality Completed NCT02742246
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Bridgeport Addiction Behavioral Over 18 Years
Countries United States
Sponsor Yale University
Condition Addiction Completed NCT02787135
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Marburg Schizophrenia Behavioral From 16 Years to 70 Years
Countries Germany
Sponsor Philipps University Marburg
Condition Schizophrenia Completed NCT03539900
This summary needs review. Please check the official study record and contact the research team for details.
In New Haven Eating disorders Drug From 18 Years to 70 Years
Countries United States
Sponsor Yale University
Condition Eating disorders Terminated NCT02439944
This summary needs review. Please check the official study record and contact the research team for details.
In Toronto Addiction Drug From 19 Years to 65 Years
Countries Canada
Sponsor Centre for Addiction and Mental Health
Condition Addiction Completed NCT03449576
This summary needs review. Please check the official study record and contact the research team for details.
In Salem PTSD Behavioral From 18 Years to 65 Years
Countries United States
Sponsor VA Office of Research and Development
Condition PTSD Completed NCT02141113
This study is completed in the United States. It focuses on ADHD.
In Rochester Hills ADHD Drug From 18 Years to 65 Years
Countries United States
Sponsor Rochester Center for Behavioral Medicine
Condition ADHD Completed EUCTR 2012-001666-15
This study is completed in Finland, in Slovakia, and in Poland. It is testing 2 doses of agomelatine (10 mg/day or 25 mg/day) for anxiety.
In Finland Anxiety Other
Countries Finland, Slovakia, Poland
Sponsor Institut de Recherches Internationales Servier
Condition Anxiety